Pharma-Bio Serv (PBSV) Stock Price, News & Analysis

Company Overview

Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. Pharma-Bio Serv, Inc. was founded in 1993 and is headquartered in Dorado, Puerto Rico.

Key Stats

• Today's Range: $0.49 to $0.58
• 50-Day Range: $0.48 to $0.59
• 52-Week Range: $0.43 to $1.36
• Volume: 4,218 shs
• Average Volume: 502 shs
• Market Capitalization: $13.39 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

PBSV Stock Analysis - Frequently Asked Questions

How have PBSV shares performed this year?

Pharma-Bio Serv's stock was trading at $0.60 on January 1st, 2026. Since then, PBSV shares have decreased by 2.6% and is now trading at $0.5845.

How were Pharma-Bio Serv's earnings last quarter?

Pharma-Bio Serv Inc. (OTCMKTS:PBSV) posted its earnings results on Tuesday, March, 17th. The company reported $1.43 earnings per share for the quarter, topping the consensus estimate of $0.02 by $1.41. The firm had revenue of $2.30 million for the quarter, compared to analyst estimates of $2.70 million. Pharma-Bio Serv had a negative trailing twelve-month return on equity of 0.66% and a negative net margin of 0.86%.

How do I buy shares of Pharma-Bio Serv?

Shares of PBSV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Pharma-Bio Serv own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Pharma-Bio Serv investors own include AT&T (T), Annaly Capital Management (NLY), BlackRock Multi-Sector Income Trust (BIT), GE Aerospace (GE), ExxonMobil (XOM), Enterprise Products Partners (EPD) and First BanCorp. (FBP).

Company Calendar

• Last Earnings: 3/17/2026
• Today: 5/07/2026
• Next Earnings (Estimated): 6/15/2026
• Fiscal Year End: 10/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Business Services
• Industry: Consulting
• Sub-Industry: Business Services
• Current Symbol: OTCMKTS:PBSV
• CIK: 1304161
• Web: www.pharmabioserv.com
• Phone: (787) 278-2709
• Fax: 787-796-5168
• Employees: 185
• Year Founded: 1993

Profitability

• EPS (Trailing Twelve Months): ($0.01)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 6.49
• P/E Growth: N/A
• Net Income: -$100 thousand
• Net Margins: -0.86%
• Pretax Margin: -0.76%
• Return on Equity: -0.66%
• Return on Assets: -0.56%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 4.03
• Quick Ratio: 4.03

Sales & Book Value

• Annual Sales: $9 million
• Price / Sales: 1.49
• Cash Flow: $0.01 per share
• Price / Cash Flow: 89.58
• Book Value: $0.52 per share
• Price / Book: 1.12

Miscellaneous

• Outstanding Shares: 22,900,000
• Free Float: 20,016,000
• Market Cap: $13.39 million
• Optionable: Not Optionable
• Beta: 0.61